Testing whether Genetic Variation Explains Correlation of Quantitative Measures of Gene Expression, and Application to Genetic Network Analysis

Por Yu, Zhaoxia, Wang, Leiwei, Hildebrandt, Michelle A.T., Schaid, Daniel J.
Publicado em 2008

Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survival

Por Tan, Weiqi, Gu, Jian, Huang, Maosheng, Wu, Xifeng, Hildebrandt, Michelle A.T.
Publicado no Mol Carcinog (2014)

Exact Tests of Hardy-Weinberg Equilibrium and Homogeneity of Disequilibrium across Strata

Por Schaid, Daniel J. , Batzler, Anthony J. , Jenkins, Gregory D. , Hildebrandt, Michelle A. T. 
Publicado em 2006

MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk

Por Wei, Hua, Ke, Hung-Lung, Lin, Jie, Shete, Sanjay, Wood, Christopher G., Hildebrandt, Michelle A.T.
Publicado em 2012

Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer

Por Xing, Jinliang, Dinney, Colin P., Shete, Sanjay, Huang, Maosheng, Hildebrandt, Michelle A., Chen, Zhinan, Gu, Jian
Publicado em 2011

Genetic Variation in MicroRNA Genes and Risk of Oral Premalignant Lesions

Por Clague, Jessica, Lippman, Scott M., Yang, Hushan, Hildebrandt, Michelle A. T., Ye, Yuanqing, Lee, Jack J., Wu, Xifeng
Publicado em 2010

Germline genetic variants in the Wnt/beta-catenin pathway as predictors of colorectal cancer risk

Por Hildebrandt, Michelle A.T., Reyes, Monica E., Lin, Moubin, He, Yonggang, Nguyen, Son V., Hawk, Ernest T., Wu, Xifeng
Publicado no Cancer Epidemiol Biomarkers Prev (2016)

Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome

Por Meng, Qing H., Xu, Enping, Hildebrandt, Michelle A.T., Liang, Dong, Lu, Karen, Ye, Yuanqing, Wagar, Elizabeth A., Wu, Xifeng
Publicado no Clin Chem (2013)

GENETIC VARIANTS WITHIN THE WNT/β-CATENIN SIGNALING PATHWAY AS INDICATORS OF BLADDER CANCER RISK

Por Pierzynski, Jeanne A., Hildebrandt, Michelle A., Kamat, Ashish M., Lin, Jie, Ye, Yuanqing, Dinney, Colin P.N., Wu, Xifeng
Publicado no J Urol (2015)

Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis

Por Reyes, Monica E., Ye, Yuanqing, Zhou, Yeling, Liang, Alexander, Kopetz, Scott, Rodriquez, M. Alma, Wu, Xifeng, Hildebrandt, Michelle A.T.
Publicado no Qual Life Res (2016)

Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy

Por Hildebrandt, Michelle A.T., Yang, Hushan, Hung, Mien-Chie, Izzo, Julie G., Huang, Maosheng, Lin, Jie, Ajani, Jaffer A., Wu, Xifeng
Publicado em 2009

Genetic Variants in TGF-β Pathway Are Associated with Ovarian Cancer Risk

Por Yin, Jikai, Lu, Karen, Lin, Jie, Wu, Lei, Hildebrandt, Michelle A. T., Chang, David W., Meyer, Larissa, Wu, Xifeng, Liang, Dong
Publicado em 2011

MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early Stage Non-Small Cell Lung Cancer Patients

Por Pu, Xia, Roth, Jack A., Hildebrandt, Michelle A.T., Ye, Yuanqing, Wei, Hua, Minna, John D., Lippman, Scott M., Wu, Xifeng
Publicado em 2013

Pathway-based serum microRNA profiling and survival in patients with advanced-stage non-small cell lung cancer

Por Wang, Yan, Gu, Jian, Roth, Jack A., Hildebrandt, Michelle A.T., Lippman, Scott M., Ye, Yuanqing, Minna, John D., Wu, Xifeng
Publicado em 2013

PI3K/PTEN/AKT/mTOR Pathway Genetic Variation Predicts Toxicity and Distant Progression in Lung Cancer Patients Receiving Platinum-based Chemotherapy

Por Pu, Xia, Hildebrandt, Michelle A.T., Lu, Charles, Lin, Jie, Stewart, David J., Ye, Yuanqing, Gu, Jian, Spitz, Margaret R., Wu, Xifeng
Publicado em 2010

Common genetic variants in cell cycle pathway are associated with survival in stage III–IV non-small-cell lung cancer

Por Yin, Jikai, Lu, Charles, Gu, Jian, Lippman, Scott M., Hildebrandt, Michelle A.T., Lin, Jie, Stewart, David, Spitz, Margaret R., Wu, Xifeng
Publicado em 2011

Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients

Por Hildebrandt, Michelle A.T., Tan, Weiqi, Tamboli, Pheroze, Huang, Maosheng, Ye, Yuanqing, Lin, Jie, Lee, Ju-Seog, Wood, Christopher G., Wu, Xifeng
Publicado em 2012

Role of Inflammatory Related Gene Expression in Clear Cell Renal Cell Carcinoma Development and Clinical Outcomes

Por Tan, Weiqi, Hildebrandt, Michelle A. T., Pu, Xia, Huang, Maosheng, Lin, Jie, Matin, Surena F., Tamboli, Pheroze, Wood, Christopher G., Wu, Xifeng
Publicado em 2011

Variations in the Vascular Endothelial Growth Factor Pathway Predict Pulmonary Complications

Por Kim, Jae Y., Hildebrandt, Michelle A.T., Pu, Xia, Ye, Yuanqing, Correa, Arlene M., Vaporciyan, Ara A., Wu, Xifeng, Roth, Jack A.
Publicado em 2012

MicroRNA expression signatures during malignant progression from Barrett’s esophagus to esophageal adenocarcinoma

Por Wu, Xifeng, Ajani, Jaffer A., Gu, Jian, Chang, David W., Tan, Weiqi, Hildebrandt, Michelle A.T., Huang, Maosheng, Wang, Kenneth Y., Hawk, Ernest
Publicado em 2013